Fulcrum Therapeutics, Inc. (FULC) earnings

FULC earnings moved a median of -2.28% by the close. Quarterly and annual FULC reports and results, each read against the price at its own news timestamp. Back to the FULC overview →

27 measured FULC earnings events.

Where these FULC earnings landedvs 25 measured FULC earnings reactions
FULC earningsMiddle 50% · -3.76% to +3.69%Zero: 0.00%Median: -2.28%Median -2.28%-5.00%0+5.00%
Middle 50% of FULC earnings reactions-3.76% to +3.69%
Median reaction (to close)-2.28%
Measured reactions25
Point-in-time · zero look-ahead

Half of the 25 FULC earnings events with a measured close landed between -3.76% and +3.69%; 36% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Fulcrum Therapeutics, For: Jun 30SEC filing · Form 10-Q-1.34%-3.76%
Form 10-Q Fulcrum Therapeutics, For: Mar 31SEC filing · Form 10-Q-9.75%-2.28%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026Press release-9.75%-2.28%
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ETPress release-0.85%-3.52%
Form 10-K Fulcrum Therapeutics, For: Dec 31SEC filing · Form 10-K-2.59%-11.09%
Form 10-Q Fulcrum Therapeutics, For: Sep 30SEC filing · Form 10-Q-0.36%-3.70%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025Press release-0.36%-3.70%
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ETPress release+1.80%-6.42%
Form 10-Q Fulcrum Therapeutics, For: Jun 30SEC filing · Form 10-Q+8.76%—
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025Press release+8.76%—
Form 10-Q Fulcrum Therapeutics, For: Mar 31SEC filing · Form 10-Q-0.78%+13.77%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025Press release-0.78%+13.77%
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ETPress release-2.08%-2.77%
Form 10-K Fulcrum Therapeutics, For: Dec 31SEC filing · Form 10-K-4.47%+3.35%
Form 10-Q Fulcrum Therapeutics, For: Sep 30SEC filing · Form 10-Q-7.87%-9.64%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024Press release-7.87%-9.64%
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ETPress release-0.29%+0.00%
Form 10-Q Fulcrum Therapeutics, For: Jun 30SEC filing · Form 10-Q-6.20%+3.69%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024Press release-6.20%+3.69%
Fulcrum Therapeutics to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, July 31, 2024, at 8:00 a.m. ETPress release-0.12%-1.83%
Form 10-Q Fulcrum Therapeutics, For: Mar 31SEC filing · Form 10-Q-1.20%-11.98%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024Press release-1.20%-11.98%
Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ETPress release-0.57%-0.90%
Form 10-K Fulcrum Therapeutics, For: Dec 31SEC filing · Form 10-K+0.49%+0.49%
Form 10-Q Fulcrum Therapeutics, For: Sep 30SEC filing · Form 10-Q+12.57%+14.71%
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023Press release+12.57%+14.71%
Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ETPress release+0.00%+8.66%
That’s how FULC usually reacts to earnings — get an email when it moves on news →
Keep exploring

More FULC: analyst actions → · SEC filings → · FULC overview →